| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 475,700 | 601,600 | 632,100 | 677,300 | | Cost of Revenue | 215,700 | 295,700 | 277,800 | 289,700 | | | Gross Profit | 260,000 | 305,900 | 354,300 | 387,600 | | | Operating Expenses | | Research Development | 52,800 | 53,500 | 59,500 | 58,400 | | Selling General and Administrative | 109,400 | 114,900 | 124,900 | 123,400 | | Non Recurring | 8,300 | 17,400 |
-
|
-
| | Others | 19,400 | 20,000 | 20,000 | 18,900 | | | | Total Operating Expenses | 189,900 | 205,800 |
-
|
-
| | | | Operating Income or Loss | 70,100 | 100,100 | 149,900 | 186,900 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 16,400 | 10,600 | (19,700) | 18,000 | | Earnings Before Interest And Taxes | 86,500 | 110,700 | 130,200 | 204,900 | | Interest Expense | 28,000 | 30,400 | 27,100 | 23,100 | | Income Before Tax | 58,500 | 80,300 | 103,100 | 181,800 | | Income Tax Expense | 20,200 | 14,600 | 51,100 | 73,400 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 38,300 | 65,700 | 52,000 | 108,400 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 38,300 | 65,700 | 52,000 | 108,400 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $38,300 | $65,700 | $52,000 | $108,400 |
|
0.45% Nasdaq 
0.20%
Income Statement
